| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.0062 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |